iBio, Inc. (IBIO) Common Stock, Shares Authorized 2011 - 2024

Historical data

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
iBio, Inc. quarterly Common Stock, Shares Authorized history and growth rate from 2011 to 2024.
  • iBio, Inc. Common Stock, Shares Authorized for the quarter ending March 31, 2024 was 275 M shares, unchanged year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 275 M 0 0% Mar 31, 2024 10-Q 2024-05-13
Q4 2023 275 M 0 0% Dec 31, 2023 10-Q 2024-02-09
Q3 2023 275 M 0 0% Sep 30, 2023 10-Q 2023-11-14
Q2 2023 275 M 0 0% Jun 30, 2023 10-Q 2024-05-13
Q1 2023 275 M 0 0% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 275 M 0 0% Dec 31, 2022 10-Q/A 2023-05-19
Q3 2022 275 M 0 0% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 275 M 0 0% Jun 30, 2022 10-K 2023-09-27
Q1 2022 275 M 0 0% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 275 M 0 0% Dec 31, 2021 10-Q 2022-02-14
Q3 2021 275 M 0 0% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 275 M 0 0% Jun 30, 2021 10-K 2022-10-11
Q1 2021 275 M 0 0% Mar 31, 2021 10-Q 2021-05-17
Q4 2020 275 M 0 0% Dec 31, 2020 10-Q 2021-02-16
Q3 2020 275 M 0 0% Sep 30, 2020 10-Q 2020-11-16
Q2 2020 275 M 0 0% Jun 30, 2020 10-K 2021-09-28
Q1 2020 275 M 0 0% Mar 31, 2020 10-Q 2020-05-15
Q4 2019 275 M 0 0% Dec 31, 2019 10-Q 2020-02-14
Q3 2019 275 M 0 0% Sep 30, 2019 10-Q 2019-11-14
Q2 2019 275 M 0 0% Jun 30, 2019 10-K 2020-10-13
Q1 2019 275 M 0 0% Mar 31, 2019 10-Q 2019-05-10
Q4 2018 275 M 0 0% Dec 31, 2018 10-Q 2019-02-13
Q3 2018 275 M +100 M +57.1% Sep 30, 2018 10-Q 2018-11-13
Q2 2018 275 M +100 M +57.1% Jun 30, 2018 10-K 2019-08-26
Q1 2018 275 M +100 M +57.1% Mar 31, 2018 10-Q 2018-05-11
Q4 2017 275 M +100 M +57.1% Dec 31, 2017 10-Q 2018-02-14
Q3 2017 175 M 0 0% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 175 M 0 0% Jun 30, 2017 10-K 2018-09-18
Q1 2017 175 M 0 0% Mar 31, 2017 10-Q 2017-05-15
Q4 2016 175 M 0 0% Dec 31, 2016 10-Q 2017-02-21
Q3 2016 175 M 0 0% Sep 30, 2016 10-Q 2017-11-09
Q2 2016 175 M 0 0% Jun 30, 2016 10-K 2017-09-15
Q1 2016 175 M 0 0% Mar 31, 2016 10-Q 2016-05-23
Q4 2015 175 M 0 0% Dec 31, 2015 10-Q 2016-02-22
Q3 2015 175 M 0 0% Sep 30, 2015 10-Q 2016-11-18
Q2 2015 175 M 0 0% Jun 30, 2015 10-K 2016-10-13
Q1 2015 175 M 0 0% Mar 31, 2015 10-Q 2015-05-15
Q4 2014 175 M 0 0% Dec 31, 2014 10-Q/A 2015-02-24
Q3 2014 175 M +75 M +75% Sep 30, 2014 10-Q 2014-11-14
Q2 2014 175 M +75 M +75% Jun 30, 2014 10-K 2015-10-13
Q1 2014 175 M +75 M +75% Mar 31, 2014 10-Q 2014-05-15
Q4 2013 175 M +75 M +75% Dec 31, 2013 10-Q 2014-02-14
Q3 2013 100 M 0 0% Sep 30, 2013 10-Q 2013-11-14
Q2 2013 100 M 0 0% Jun 30, 2013 10-K 2015-10-13
Q1 2013 100 M 0 0% Mar 31, 2013 10-Q 2013-05-20
Q4 2012 100 M 0 0% Dec 31, 2012 10-Q 2013-02-19
Q3 2012 100 M 0 0% Sep 30, 2012 10-Q 2012-11-14
Q2 2012 100 M 0 0% Jun 30, 2012 10-K/A 2013-10-04
Q1 2012 100 M Mar 31, 2012 10-Q 2012-05-15
Q4 2011 100 M Dec 31, 2011 10-Q 2012-02-14
Q3 2011 100 M Sep 30, 2011 10-Q 2011-11-14
Q2 2011 100 M Jun 30, 2011 10-K/A 2012-10-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.